A new class of antibiotics has shown promise in preclinical trials against drug-resistant tuberculosis. The corresponding study was published in PLOS Biology. Each year, around 1.5 million people die from Mycobacterium tuberculosis infection. Although antibiotics exist to treat the bacteria, multi-drug resistant, extensively drug-resistant, and totally drug-resistant strains have developed, and pose a significant health risk. […]
New Antibiotic Shows Promise Against Treatment-Resistant Tuberculosis Read More »









